InflaRx
IFRX
30 hedge funds and large institutions have $10.5M invested in InflaRx in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 3 closing their positions.
207% more call options, than puts
Call options by funds: $86K | Put options by funds: $28K
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
38% more capital invested
Capital invested by funds: $7.63M → $10.5M (+$2.91M)
11% more funds holding
Funds holding: 27 → 30 (+3)
2.86% less ownership
Funds ownership: 11.9% → 9.04% (-2.9%)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$360K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$59K |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$36.1K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$21.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$12.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Suvretta Capital Management
New York
|
-$2.56M |
| 2 |
Millennium Management
New York
|
-$181K |
| 3 |
Morgan Stanley
New York
|
-$165K |
| 4 |
FIA
FNY Investment Advisers
New York
|
-$116K |
| 5 |
Renaissance Technologies
New York
|
-$107K |
IFRX Hedge Fund Activity: Q3 2022 in Review
30 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q3 2022, worth a combined $10.5M — up 38% from $7.63M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new IFRX positions and 3 closed out — a net gain of 3 holders — while 5 added to existing stakes and 9 trimmed.
The largest buyer was Invesco, adding an estimated $360K. The largest seller was Suvretta Capital Management, cutting an estimated $2.56M.
- 30 institutional investors held InflaRx (IFRX) as of Q3 2022, up from 27 in Q2 2022.
- Funds reported $10.5M of InflaRx stock for Q3 2022, up 38% quarter-over-quarter.
- 6 funds opened new InflaRx positions in Q3 2022 and 3 closed out, a net change of +3 holders.
- The largest InflaRx buyer in Q3 2022 was Invesco, an estimated $360K added.
- The largest InflaRx seller in Q3 2022 was Suvretta Capital Management, an estimated $2.56M sold.
Based on aggregated 13F filings for Q3 2022.